Health Care in Transition Ser.: Medicare Part d Prescription Drug Benefit : Elements, Provisions and Integrity Issues by Elena Marshall (2015, Hardcover)
Great Book Prices Store (332482)
96.6% positive Feedback
Price:
US $152.85
Approximately£114.56
+ $19.99 postage
Estimated by Tue, 6 May - Wed, 21 MayEstimated delivery Tue, 6 May - Wed, 21 May
Returns:
14 days return. Buyer pays for return postage. If you use an eBay delivery label, it will be deducted from your refund amount.
Condition:
NewNew
Medicare Part D Prescription Drug Benefit : Elements, Provisions and Integrity Issues, Hardcover by Marshall , Elena (EDT), ISBN 1634825241, ISBN-13 9781634825245, Brand New, Free shipping in the US
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
About this product
Product Identifiers
PublisherNOVA Science Publishers, Incorporated
ISBN-101634825241
ISBN-139781634825245
eBay Product ID (ePID)215391170
Product Key Features
Number of Pages113 Pages
LanguageEnglish
Publication NameMedicare Part D Prescription Drug Benefit : Elements, Provisions and Integrity Issues
SubjectMedical Law & Legislation, Medicaid & Medicare, Insurance / General
Publication Year2015
TypeTextbook
Subject AreaLaw, Business & Economics, Medical
AuthorElena Marshall
SeriesHealth Care in Transition Ser.
FormatHardcover
Dimensions
Item Weight11 Oz
Item Length9.1 in
Item Width6.1 in
Additional Product Features
LCCN2015-304968
Dewey Edition23
IllustratedYes
Dewey Decimal368.38/24
Table Of ContentPreface; Medicare Part D Prescription Drug Benefit; Medicare Program Integrity: CMS Pursues Many Practices to Address Prescription Drug Fraud, Waste & Abuse; Index.
SynopsisThe Medicare Prescription Drug, Improvement, and Modernization Act of 2003 established a voluntary, outpatient prescription drug benefit under Medicare Part D, effective January 1, 2006. Medicare Part D provides coverage through private prescription drug plans (PDPs) that offer only drug coverage, or through Medicare Advantage (MA) prescription drug plans (MA-PDs) that offer coverage as part of broader, managed care plans. Private drug plans participating in Part D bear some financial risk, though federal subsidies cover most program costs in an effort to encourage participation and keep benefits affordable. This book discusses the prescription drug benefit of Medicare Part D. It also examines practices for promoting prescription drug program integrity, and the extent that CMS's oversight of Medicare Part D program integrity, including the program integrity contractors, reflects these practices.